Jens Juul Holst

Jens Juul Holst

Professor


  1. Published

    Changes in serum leptin do not correlate to total fat mass in patients with thyrotoxicosis. / Zimmermann-Belsing, T.; Dreyer, M.; Holst, J.J.; Feldt-Rasmussen, U.

    In: J. Endocrinol., No. 49, 1998, p. 589-595.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Glucagon-like peptide-2 inhibits centrally induced antral motility in pigs. / Wojdemann, M.; Wettergren, A.; Hartmann, Bolette; Holst, J.J.

    In: Scandinavian Journal of Gastroenterology, No. 33, 1998, p. 828-832.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Inhibition of human gastric lipase secretion by glucagon-like peptide-1. / Wojdemann, M.; Wettergren, A.; Sternby, B.; Holst, J.J.; Larsen, S.; Rehfeld, J.F.; Olsen, O.

    In: Dig. Dis. Sci., No. 43, 1998, p. 799-805.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Overnight GLP-1 normalizes fasting but not daytime plasma glucose levels in NIDDM patients. / Willms, B.; Idowu, K.; Holst, J.J.; Creutzfeldt, W.; Nauck, M.A.

    In: Exp. Clin. Endocrinol. Diabetes, No. 106, 1998, p. 103-107.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    The inhibitory effect of glucagon-like peptide-1 (7-36) amide on antral motility is antagonized by its N-terminally truncated primary metabolite GLP-1 (9-36) amide. / Wettergren, A.; Wojdemann, M.; Holst, J.J.

    In: Peptides, No. 19, 1998, p. 877-882.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Amidated and non-amidated glucagon-like peptide-1 (GLP-1): non-pancreatic effects (cephalic phase acid secretion) and stability in plasma in humans. / Wettergren, A.; Pridal, L.; Wöjdemann, M.; Holst, J.J.

    In: Regul. Pept., No. 77, 1998, p. 83-88.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Glucagon-like peptide-1 inhibits gastropancreatic function by inhibiting central parasympathetic outflow. / Wettergren, A.; Wojdemann, M.; Holst, J.J.

    In: Am. J. Physiol., No. 275, 1998, p. G984-G992.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Glucagon-like peptide-1 retards gastric emptying and small bowel transit in the rat: Effect mediated through central or enteric nervous mechanisms. / Tolessa, T.; Gutniak, M.K.; Holst, J.J.; Efendic, S.; Hellstrom, P.M.

    In: Dig. Dis. Sci., No. 43, 1998, p. 2284-2290.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin. / Tolessa, T.; Gutniak, M.K.; Holst, J.J.; Efendic, S.; Hellstrom, P.M.

    In: J. Clin. Invest., No. 102, 1998, p. 764-774.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycaemia. / Toft-Nielsen, M; Madsbad, Sten; Holst, Jens Juul.

    In: Diabetologia, Vol. 41, No. 10, 1998, p. 1180-1186.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    The ethanol augmentation of glucose-induced insulin secretion is abolished by calcium antagonism with nifedipine: No evidence for a role of glucagon-like peptide-1 (GLP-1). / Svartberg, J.; Holst, J.J.; Gutniak, M.K.; Adner, N.

    In: Pancreas, No. 16, 1998, p. 66-71.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in Type 2 diabetic patients. / Seifarth, C.; Bergmann, Jesper; Holst, J.J.; Ritzel, R.; Schmiegel, W.; Nauck, M.A.

    In: Diabet. Med., No. 15, 1998, p. 485-491.

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. Published

    Isolation and molecular characterization of porcine calcitonin gene-related peptide (CGRP) and its endocrine effects in the porcine pancreas. / Rasmussen, T N; Bersani, M; Schmidt, P; Thim, L; Kofod, Hans; Jørgensen, P N; Poulsen, S S; Holst, J J.

    In: Pancreas, Vol. 16, No. 2, 03.1998, p. 195-204.

    Research output: Contribution to journalJournal articleResearchpeer-review

  14. Published

    Glucagon-like peptide 1 increases mass but not frequency or orderliness of pulsatile insulin secretion. / Porksen, N.; Grøfte, T.; Nyholm, Birgit; Holst, J.J.; Pincus, S.M.; Veldhuis, J.D.; Schmitz, O.; Butler, P.C.

    In: Diabetes, No. 47, 1998, p. 45-49.

    Research output: Contribution to journalJournal articleResearchpeer-review

  15. Published

    Normalization of sting glycemia by intravenous GLP-1 (7-36amide) or (7-37) in Type 2 diabetic patients. / Nauck, M.A.; Weber, I.; Bach, I.; Richter, S.H.; Ørskov, C.; Holst, J.J.; Schmiegel, W.

    In: Diabetic Medicine, No. 15, 1998, p. 937-945.

    Research output: Contribution to journalJournal articleResearchpeer-review

  16. Published

    Influence of glucagon-like peptide 1 on fasting glycemia in type 2 diabetic patients treated with insulin after sulfonylurea secondary failure. / Nauck, M.A.; Sauerwald, A.; Ritzel, R.; Holst, J.J.; Schmiegel, W.

    In: Diabetes Care, No. 21, 1998, p. 1925-1931.

    Research output: Contribution to journalJournal articleResearchpeer-review

  17. Published

    Normalization of fasting glycaemia by intravenous GLP-1 ([7-36 amide] or [7-37]) in type 2 diabetic patients. / Nauck, M A; Weber, I; Bach, I; Richter, S; Orskov, C; Holst, J J; Schmiegel, W.

    In: Diabetic Medicine Online, Vol. 15, No. 11, 11.1998, p. 937-45.

    Research output: Contribution to journalJournal articleResearchpeer-review

  18. Published

    Distal small bowel hormones: Correlation with fasting antroduodenal motility and gastric emptying. / Naslund, E.; Gryback, P.; Backman, L.; Jacobsson, H.; Holst, J.J.; Theodorsson, E.; Hellstrom, P.M.

    In: Dig. Dis. Sci., No. 43, 1998, p. 945-952.

    Research output: Contribution to journalJournal articleResearchpeer-review

  19. Published

    Importance of small bowel peptides for the improved glucose metabolism 20 years after jejunoileal bypass for obesity. / Naslund, E.; Backman, L.; Holst, J.J.; Theodorsson, E.; Hellstrom, P.M.

    In: Obes. Surg., No. 8, 1998, p. 253-260.

    Research output: Contribution to journalJournal articleResearchpeer-review

  20. Published

    Transplantable rat glucagonomas cause acute onset of severe anorexia and adipsia despite highly elevated NPY mRNA levels in the hypothalamic arcuate nucleus. / Jensen, P.B.; Blume, N.; Mikkelsen, J.D.; Larsen, P.J.; Jensen, H.I.; Holst, J.J.; Madsen, O.D.

    In: J. Clin. Invest., No. 101, 1998, p. 503-510.

    Research output: Contribution to journalJournal articleResearchpeer-review

  21. Published

    Treatment of type 2 diabetes with glucagonlike peptide 1. / Holst, J.J.

    In: Current Opinion in Endocrin. and Diabetes, No. 5, 1998, p. 108-115.

    Research output: Contribution to journalJournal articleResearchpeer-review

  22. Published

    Obesity - did anything happen since leptin? / Holst, J.J.

    In: Ugeskrift for læger, No. 160, 1998, p. 1182-1184.

    Research output: Contribution to journalJournal articleResearchpeer-review

  23. Published

    Nutrients of animal origin and function of gut hormones. / Holst, J.J.

    Food and Health: Role of Animal Products. Paris : Elsevier, 1998. p. 13-22.

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearch

  24. Published

    Glucagon-like peptide-1 - a new hormone and a new drug. / Holst, J.J.

    In: Ugeskrift for læger, No. 160, 1998, p. 2371-2377.

    Research output: Contribution to journalJournal articleResearchpeer-review

  25. Published

    Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1. / Holst, J.J.; Gromada, K.; Rorsman, P.

    In: Pflugers Arch., No. 435, 1998, p. 583-594.

    Research output: Contribution to journalJournal articleResearchpeer-review

  26. Published

    Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes. / Holst, J.J.; Deacon, C.F.

    In: Diabetes, No. 47, 1998, p. 1663-1670.

    Research output: Contribution to journalJournal articleResearchpeer-review

  27. Published

    On the treatment of diabetes mellitus with glucagon-like peptide-1. / Holst, J.J.; Deacon, C.F.; Toft-Nielsen, M.; Bjerre-Knudsen, L.

    In: Annals of the New York Academy of Sciences, No. 865, 1998, p. 336-343.

    Research output: Contribution to journalJournal articleResearchpeer-review

  28. Published

    Regulatory Peptides of the Gut. / Holst, J.J.

    Small Bowel Disorders. Kluwer Academic Publishers, 1998.

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearch

  29. Published

    Glucagon-like peptide 1 (7-36) amide stimulates exocytosis in human pancreatic beta-cells by both proximal and distal regulatory steps in stimulus-secretion coupling. / Gromada, J; Bokvist, K; Ding, W G; Holst, J J; Nielsen, Jens Høiriis; Rorsman, P.

    In: Diabetes, Vol. 47, No. 1, 1998, p. 57-65.

    Research output: Contribution to journalJournal articleResearchpeer-review

  30. Published

    Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. / Flint, A.; Raben, Anne; Astrup, Arne; Holst, Jens Juul.

    In: Journal of Clinical Investigation, Vol. 101, No. 3, 1998, p. 515-520.

    Research output: Contribution to journalJournal articleResearchpeer-review

  31. Published

    Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig. / Deacon, C.F.; Hughes, T.E.; Holst, J.J.

    In: Diabetes, No. 47, 1998, p. 764-769.

    Research output: Contribution to journalJournal articleResearchpeer-review

  32. Published

    Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity. / Deacon, C.F.; Knudsen, L.B.; Madsen, K.; Wiberg, F.C.; Jacobsen, O.; Holst, J.J.

    In: Diabetologia, No. 41, 1998, p. 271-278.

    Research output: Contribution to journalJournal articleResearchpeer-review

  33. Published

    Discovery of amino acid variants in the human glucose-dependent insulinotropic polypeptide (GIP) receptor: the impact on the pancreatic beta cell responses and functional expression studies in CHL cells. / Almind, K.; Ambye, Louise; Urhammer, S.A.; Hansen, T.; Echwald, S.M.; Holst, J.J.; Gromada, Jesper Lindgren; Thorens, B.; Pedersen, O.

    In: Diabetologia, No. 41, 1998, p. 1194-1198.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 4207